Tip

Swipe om te navigeren naar een ander artikel

12-01-2018 | Editor’s Comment | Uitgave 2/2018 Open Access

Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?

Tijdschrift:: Netherlands Heart Journal > Uitgave 2/2018

Auteurs:: S. W. E. Baalman, J. R. de Groot

» Naar de volledige tekst

Without Abstract

Onze productaanbevelingen

Netherlands Heart Journal

Het Netherlands Heart Journal wordt uitgegeven in samenwerking met de Nederlandse Vereniging voor Cardiologie en de Nederlandse Hartstichting. Het tijdschrift is Engelstalig en wordt gratis beschikbaa ...

Meer informatie

Gezondheidsraad. Rijgeschiktheid van personen met een geïmplanteerde cardioverter-defibrillator. Den Haag: Gezondheidsraad; 2000.

Commissie Schalij. Rijgeschiktheid van personen met een ICD: een advies tot herziening van de regelgeving. Leiden: Commissie Schalij; 2004.

Staatscourant. Regeling van de Minister van Infrastructuur en Waterstaat. 2017. https://zoek.officielebekendmakingen.nl/stcrt-2017-69981.html. Accessed 8 Dec 2017.

Curtis AB, Conti JB, Tucker KJ, Kubilis PS, Reilly RE, Woodard DA. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol. 1995;26:180–4. CrossRefPubMed

Jung W, Anderson M, Camm AJ, et al. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on ‘ICD and Driving’ of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J. 1997;18:1210–9. CrossRefPubMed

Simpson C, Dorian P, Gupta A, et al. Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. Can J Cardiol. 2004;20(13):1314–20. PubMed

Thijssen J, Borleffs CJ, van Rees JB, et al. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. Eur Heart J. 2011;32:2678–87. CrossRefPubMedPubMedCentral

Watanabe E, Abe H, Watanabe S. Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers. J Arrhythm. 2017;33:594–601. CrossRefPubMedPubMedCentral

Vehmeijer JT, Brouwer TF, Limpens J, et al. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. Eur Heart J. 2016;37:1439–48. CrossRefPubMedPubMedCentral

10.

Nordkamp OLRA, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13(2):443–54. https://doi.org/10.1016/j.hrthm.2015.09.010. CrossRef

11.

Albert CM, Rosenthal L, Calkins H, et al. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol. 2007;50:2233–40. CrossRefPubMed

12.

Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med. 2001;345:391–7. CrossRefPubMed

13.

Trappe HJ, Wenzlaff P, Grellman G. Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period. J Interv Card Electrophysiol. 1998;2:193–201. CrossRefPubMed

14.

Wilkoff BL, Williamson BD, Stern RS, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52:541–50. CrossRefPubMed

15.

Saeed M, Hanna I, Robotis D, et al. Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol. 2014;25:52–9. CrossRefPubMed

16.

Bjerre J, et al. Risk of motor vehicle accidents in patients with an implantable cardioverter defibrillator – a Danish nationwide study. Presentation at: ESC 2016. 2016.

17.

Jongejan N, Timmermans I, Elders J, et al. Driving restrictions for Dutch patients with an implantable cardioverter defibrillator: compliance and associated factors. Neth Heart J. 2018;26. https://doi.org/10.1007/s12471-017-1067-z. CrossRef

Titel: Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?
Auteurs:: S. W. E. Baalman
J. R. de Groot
Publicatiedatum: 12-01-2018
DOI: https://doi.org/10.1007/s12471-017-1072-2
Uitgeverij: Bohn Stafleu van Loghum
Tijdschrift: Netherlands Heart Journal
Uitgave 2/2018
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Tip

Swipe om te navigeren naar een ander artikel

Without Abstract

Onze productaanbevelingen

Netherlands Heart Journal

Andere artikelen Uitgave 2/2018

Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction

Driving restrictions for Dutch patients with an implantable cardioverter defibrillator

Extracorporeal life support in cardiogenic shock: indications and management in current practice

An irregular atrial tachycardia

Saphenous vein graft percutaneous coronary intervention

An irregular atrial tachycardia